Johansen 2016.
Study characteristics | |||
Patient sampling | Study design: prospective cohort study. Participants: pregnant women selected at high risk of fetal aneuploidy presenting for invasive testing. Inclusion criteria: singleton pregnancies. Exclusion criteria: multifetal pregnancies. | ||
Patient characteristics and setting | Number enrolled: 375 pregnant women (184 for the validation set). Number available for 2 x 2 table: 173 pregnant women (subgroup of 94%). Setting: Danish public health setting. Recruitment period: not reported. Ethnicity: not reported. Median gestational age (range): 13.4 (10.6 to 31) weeks. Maternal age: not reported. Relevant tests carried out prior to index test: ultrasonography (nuchal translucency measurement) or biochemical screening or both. Language of the study: English. | ||
Index tests | gNIPT by MPSS on Ion Proton™ sequencer in 5‐plex. Fetal fraction DNA: amount measured but not reported. Blood samples for gNIPT were collected just before reference standard. Cutpoint: positive if Z score ≥ 4 and WISECONDOR ≥ 1% (unclassified if Z score between 3 and 4). In‐house test. |
||
Target condition and reference standard(s) | Target conditions: T21, T18 and T13. Reference standard: fetal karyotype of chorionic villi or amniotic fluid. | ||
Flow and timing | Blood samples for gNIPT were obtained just prior the invasive procedure (reference standard).
gNIPT was a second‐tier test. 191/375 not selected, samples for the validation set were excluded. 11/184 samples failed during sequencing process for low fetal fraction DNA (no gNIPT result). 2/173 samples were resequenced because gNIPT results were in the inconclusive zone and 2 results were obtained. |
||
Comparative | |||
Aim to study | To introduce gNIPT for fetal autosomal trisomies and gender in a Danish public health setting, using semi‐conductor sequencing and published open source scripts for analysis. | ||
Funding source or sponsor of the study | No funding source was reported. | ||
Informations about the authors contacted | No need for further contact. | ||
Notes | |||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
High | Low | ||
DOMAIN 2: Index Test MPSS | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Low | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all analysed patients receive the reference standard? | Yes | ||
Were all patients included in the analysis? | No | ||
High |